Introduction
Hypercoagulable states are increasingly reported in patients with peripheral arterial disease 1-8 and may be associated with the failure of revascularisation. 1-5' 9' 1° The purpose of this prospective study was to investigate whether preoperative hypercoagulable abnormalities are independently related to failure of arterial reconstruction, and to document the levels of natural anticoagulants following revascularisation for leg ischaemia.
Patients and Methods
Sixty consecutive patients undergoing planned arterial revascularisation for stable leg ischaemia between January 1992 and November 1993 were studied. Patients undergoing prophylactic bypass for popliteal or anastomotic aneurysms, or emergency revascularisation * Please address all correspondence to: S.A. Ray, 48 Lysias Road, London SW12 8BP, U.K.
for acute limb ischaemia, were excluded. All patients underwent peroperative completion arteriography to exclude technical deficiencies and were administered 5000 IU subcutaneous heparin twice daily until mobile, and 150mg aspirin daily. The day before surgery venous blood was drawn for routine blood screen measurements and a thrombophilia screen (see below). Sampling was repeated on the first and third postoperative day, and then again after 1 and 6 months. At each of these visits continuing patency of the arterial reconstruction was ascertained by a sustained postoperative improvement of ankle-brachial pressure index of 0.15 or more and, where doubtful, confirmed by digital subtraction angiography. Patients were discharged from this study 1 year following reconstruction.
Blood samples
A 20 ml volume of venous blood was taken for routine screen including haematocrit, platelet count, liver function, and levels of serum cholesterol and triglyceride.
A further 10 ml was drawn into 5 ml vacuum tubes containing 0.5 ml 0.11 mmol/l sodium citrate, doublespun at 5°C and 300 rpm for 20 min, and stored at -70 ° C. Samples were later thawed and assayed in batches for a thrombophilia screen, which consisted of:
(1) A clotting screen (prothrombin time, kaolin partial thromboplastin time and thrombin time) with correction tests where appropriate. (2) Functional (chromogenic) assays of antithrombin III and activated protein C (Immunochrom PC/ AT III; Immuno, Vienna, Austria) (3) Immunological (enzyme-linked immunosorbent) assay of free protein S after precipitation of bound protein S with polyethylene glycol. 11 (4) Tests for lupus anticoagulant including a dilute Russell viper venom test 12 with phospholipid neutralisation step and a kaolin clotting time. All assays have been validated in the authors' laboratory using 50 donors, from whom ranges were derived, international reference plasmas were used where available; protein S has no international standard and its level is quoted as a percentage of normal plasma concentrations. such abnormalities increased the 1 year failure rate of reconstruction from 30 to 60% it was calculated that a minimum of 50 patients would be required to show a statistical difference at the 95% level.
Twelve months following surgery patients were allocated to the Patent group if their reconstruction was still functioning and to the Occluded group if it had failed. The two groups were compared with respect to the prevalence of accepted risk factors for bypass occlusion, the nature of revascularisation, the preoperative white blood cell count and hypercoagulable abnormalities. Discrete variables were analysed using the Chi-squared test with Yates' correction where necessary. The Student t-test or Mann-Whitney U-test were used for comparing continuous variables. The calculation of independent risk factors for occlusion was performed by logistic regression analysis using an SAS programme (SAS Institute Incorporated, U.S.A.).
Results

Preoperative patient characteristics and previous revascularisation
Interpretation of assays
Protein C, protein S and antithrombin III assays were performed twice on the same sample. If any level was less than the laboratory normal range of 70-130 units/ dl (70-130% for protein S) the test was reported as abnormal and repeated at a later date when possible. Protein C and S levels were not interpreted if patients were receiving warfarin whilst antithrombin III levels were not performed if the patients were receiving intravenous heparin. These patients were still included since other hypercoagulable abnormalities could be tested. Heparin-associated thrombocytopaenia was suspected if there was a fall in platelet count of more than 100 x 109/1 from the preoperative count and confirmed by the observation of platelet aggregation when mixing patient serum with donor platelets in the presence of heparin. 13
Analysis of results
On the basis of a prevalence study at our unit 1 it was estimated that at least 25% of recruited patients would have a hypercoagulable abnormality. Assuming that Sixteen (27%) of the 60 patients undergoing peripheral arterial reconstruction were diabetic and 23 (38%) were smokers at the time of admission. Forty-six (77%) of the procedures were performed for ischaemic rest pain or ulceration whilst the remainder had revascularisation to alleviate disabling claudication. Thirty-eight (63%) patients had a history of previous surgical or percutaneous revascularisation. Twentyfive (42%) had undergone up to three surgical reconstructions and in 14 patients prosthetic graft material was still present. Nineteen (32%) patients had undergone up to four percutaneous attempts at relieving peripheral ischaemia, and this had involved thrombolysis in five cases.
Postoperative clinical course
Failure of arterial reconstruction was suffered by 20 (33%) patients (Occluded group) after a median postoperative interval of 2 weeks (range i day to 7 months following surgery). Twelve of these occurred within 1 month of surgery. One patient died from a postoperative myocardial infarct and another died within the follow-up period. Seven required major amputation (3 below-knee, I through-knee, 3 above-knee) and five had further reconstructive surgery. Of the 40
Eur J Vasc Endovasc Surg Vo113, April 1997 Table 1 shows the patient characteristics, indications for intervention and nature of arterial reconstruction in the Patent and Occluded groups. There was an increased proportion of femorodistal reconstructions in the Patent group and of surgical thrombectomy in the Occluded group but these were not statistically significant.
Causes of failed reconstruction
Duplex ultrasound surveillance of reconstruction was not available during the study period and there was no information on graft haemodynamics before failure. In two patients the anatomical cause of failure was not sought as reintervention was not contemplated. Two more patients had a failed attempt at thrombolysis. In the remaining 16 patients imaging during arteriography or direct inspection at re-operation enabled the probable cause of failure to be identified in eight cases: three patients had significant intimal hyperplasia at proximal or distal anastomoses and three more had progression of distal atheroma. One patient had a kink in a PTFE graft and another had a stenosed valve in a reversed saphenous vein graft. In the remaining eight patients there was no obvious anatomic reason for failure. 
Nature of hypercoagulable abnormalities before surgery
Heparin-associated thrombocytopenia
Heparin-associated thrombocytopenia was tested for in four patients and detected in two. The first was a 64-year-old woman being treated with intravenous heparin for deep venous thrombosis. Ischaemia developed in the same leg and necessitated iliofemoral thrombectomy, at which a typical "white clot" of platelet thrombus was retrieved. Her postoperative platelet count was 55 x 109/1 and reocclusion occurred the following day. Despite further thrombectomy and thrombolysis an above-knee amputation was required. The second patien t was a 38-year-old diabetic woman who developed an ischaemic foot during admission for ketoacidosis. This was initially treated with intravenous heparin and arteriography demonstrated infrapopliteal thrombus which did not respond to lytic agents. Surgical thrombectomy revealed characteristic "white clot" of platelets in the tibioperoneal trunk. Platelet count was 39 x 109/1 by the third postoperative day. The leg ischaemia progressed proximally and above-knee amputation was performed, following which she suffered a thrombotic stroke. Heparin-associated platelet aggregation was confirmed in both cases.
Significance of preoperative hypercoagulable abnormality
Nearly 40% of the study patients who had undergone a previous revascularisation procedure had a hypercoagulable abnormality in contrast to 27% of those There was no significant difference in the prevalence of preoperative hypercoagulable abnormalities between diabetics and non-diabetics (45% vs. 31%, Chisquared=0.73, 1 df, p=0.39), smokers and nonsmokers (35% vs. 40%, Chi-squared =0.06, 1 dL p = 0.81), and claudicants and patients with ischaemic rest pain or ulceration (33% vs. 45%, Chi-squared = 0.15, 1 df, p = 0.70). Table 2 compares the hypercoagulable abnormalities detected prior to surgery in the Patent and Occluded groups. Overall, abnormalities were detected over three times more frequently in the Occluded than Patent groups (p<0.01) with the lupus anticoagulant being found seven times more often in the Occlusion group (p<0.01). Of the 12 patients suffering failure within 1 month of surgery preoperative hypercoagulable abnormalities were found in 11 (92%), nearly four times more frequently than that found in the eight patients whose reconstruction failed after the first postoperative month (92% vs. 25%, Chi-squared = 6.68, p<0.01). Table 3 demonstrates that the only independent variable significantly associated with failure of reconstructive surgery was a pre-existing hypercoagulable abnormality, usually due to the effect of the lupus anticoagulant. Smokers and diabetics were also more likely to suffer reconstruction failure but this was not significant. Table 4 lists details of the eight patients in whom there was no apparent reason at imaging or operation for the failure of reconstruction. Five were female, contrasting with the male predominance of the study group as a whole. Furthermore, they were approximately a decade younger than patients who had an identifiable cause for failure of arterial reconstruction (58.6 vs. 68.2 years, t = 1.63, p = 0.12). Five of the eight patients had a preoperative hypercoagulable abnormality, and two of these had more than one abnormality. Of the remaining three patients with normal preoperative thrombophilia screens, one had already undergone several revascularisation procedures and also suffered from Crohn's disease. Another was receiving chemotherapy for oesophageal carcinoma.
The three patients who died postoperatively all had low preoperative protein S levels (50%, 63%, 66%), significantly different from preoperative protein S levels in the surviving 57 patients (59.7% vs. 103.8%; t=2.5, 52 d.f., p=0.02). All three had undergone revascularisation for either rest pain or ischaemic ulceration. A low protein S level before surgery was significantly associated with postoperative death (Chisquared = 10.11, 1 d.f., p=0.002). Figure 1 shows the prevalence of hypercoagulable abnormalities during the 6 months following surgical revascularisation for leg ischaemia. By the third postoperative day the majority of patients had an abnormality, usually of the natural anticoagulants protein C or protein S. Six months following surgery the only abnormalities detected were of a low protein S or the lupus anticoagulant. Figure 2 shows the prevalence of any hypercoagulable abnormality before and for 6 months following surgery in both the Patent and Occluded groups. There was no further increase in the prevalence of abnormalities in the Occluded group in the early postoperative period, although the nature of abnormalities did change with those of the natural anticoagulants predominating. The different prevalence of hypercoagulable abnormalities between the Eur J Vasc Endovasc Surg Vol 13, April 1997 Patent and Occluded groups was maximal before reconstruction.
Changes in hypercoagulable abnormalities following surgery
Discussion
In a previous study we noted that patients with a failed peripheral arterial reconstruction were more likely to have hypercoagulable abnormalities than those with patent grafts. 1 Prospective studies have confirmed the association between preoperative hypercoagulable abnormalities and subsequent graft failure but neither the nature of the revascularisation, nor the role of other risk factors for occlusion, have been simultaneously analysed. 2' 3 The relatively high failure rate following arterial reconstruction in this study is consistent with previous figures from this and other units 14' 15 and may reflect the high proportion of limbsalvage procedures (77%) and tibial anastomoses (23%). The high proportion of inserted prosthetic grafts (38%) reflects similar published patency rates to vein grafts above the knee, and a lack of suitable autogenous vein for four distal bypasses. However, all prosthetic bypasses below the knee had an adjuvant venous anastomotic patch and the proportion of such grafts in the Patent and Occluded groups was similar. There was no ultrasound graft surveillance at the time but in only two cases were technical deficiencies thought to be a significant factor in occlusion.
The high prevalence of hypercoagulable abnormalities detected prior to surgery in this study (35%) is similar to that reported in clinically stable claudicants attending our unit ~ and therefore unlikely to be related to the consumption of natural anticoagulants during acute ischaemia. Certainly there was no significant difference in the prevalence of abnormalities in this study between claudicants and those with more severe ischaemia. Furthermore, 11 of the 21 patients with hypercoagulable abnormalities had the lupus anticoagulant or heparin-associated thrombocytopaenia, which are not precipitated by ischaemic changes or thrombosis per se.
Natural anticoagulant levels decreased following revascularisation, with over 50% of patients becoming deficient in protein C, protein S or antithrombin III (Fig. 1) . Protein C and antithrombin III levels were restored one month later but protein S took longer. Postoperative falls of 10-30% in both antithrombin II116'I7 and protein C x8 have been noted previously with the nadir on the third postoperative day and restoration to normal levels by 1 week. ~7' 18 There are several hypotheses for the decrease in natural anticoagulants following surgery: tissue damage induces low-grade DIC with increased circulating thrombin 19 and increased activation and consumption of protein C. Blood loss during surgery may also decrease the pool of natural anticoagulants, 2° which is not replenished by transfusion. I6
In this study the detection of a hypercoagulable abnormality before revascularisation was independently predictive of subsequent failure of arterial reconstruction. Postoperative measurements were of less predictive value (Fig. 2) . Although this unit has previously found the preoperative white blood cell count to be independently predictive of femoropopliteal graft failure, 14 we only studied 24 such Eur I Vasc Endovasc Surg Vol 13, April 1997 procedures and were unable to confirm or refute this finding. Neither smoking nor diabetes was significantly associated with postoperative failure of reconstruction. This appears to be contrary to some published data 21 but may be reconciled by the relatively short time to failure in this study. Wiseman et al. have also reported no difference in the patency rates 6 months following femoropopliteal vein bypass in those with serum markers of continued smoking and those confirmed to be non-smokers. 2~ The adverse effects of smoking and diabetes are predominantly mediated via the progression of atherosclerosis which is thought to be the principal cause of late graft failure. 22' 23 By contrast hypercoagulable abnormalities appear to be of greatest significance in early (within 1 month) failure. The most important abnormalities in this respect was the lupus anticoagulant which was detected in nine (15%) patients. Previous investigators have reported the presence of the lupus anticoagulant in between 3.5 and 45% of arteriopaths. 2' 5' s' 24 This large variation in prevalence is at least partly due to the method of identifying the lupus anticoagulant. For example, Fligelstone et al. noted that use of a prolonged activated partial thromboplastin time alone to screen for the lupus anticoagulant would have identified only 12% of the cases discovered by the currently accepted tests, s In this study we also used the dilute Russell viper venom time to detect the lupus anticoagulant as recommended by both national 25 and international 26 working parties. None of these patients had an abnormal KCCT.
In our study the lupus anticoagulant carried a positive predictive value for reconstructive failure of 67% in this study (Chi-squared =4.24, 1 df, p<0.05). Taylor et al. found that arteriopaths with anti-phospholipid antibodies (anticardiolipin or the lupus antibodies) were 1.8 times as likely to have had previous lower extremity revascularisation (p<0.05) and 5.6 times as likely to have suffered failure of that procedure (p<0.01) than patients who did not have these antibodies, s We have previously postulated that the lupus anticoagulant may appear as a result of exposure to prosthetic material ~ and in this study it was detected four times more frequently in patients with prosthetic grafts in situ.
Thirty-eight percent of patients with preoperative hypercoagulable abnormalities did not suffer reocclusion which suggests that other factors such as a low-flow state or a technical deficiency may be required before the reconstruction is at risk. Alternatively multiple abnormalities per se may jeopardise arterial reconstruction. For example two of the three patients with two or more hypercoagulable abnormalities before reconstruction suffered occlusion for no apparent other reason (Table 4 ). Up to 20% of graft failures do not have an obvious cause 27 and some of these may represent spontaneous thrombosis resulting from a hypercoagulable state. It is not clear why three patients suffered occlusion despite a normal thrombophilia screen (Table 4 ) but two had systemic illnesses which are associated with a tendency to thrombosis. TM They may have had underlying hypercoagulable abnormalities for which tests were not available at the start of the study, for example activated protein C resistance.
An unexpected finding was the association of a low protein S level and postoperative mortality, However, all three cases had limb-threatening ischaemia which carries a higher mortality than surgery for claudication. In two of the patients the cause of death was ischaemic heart disease. There is little information on the association of hypercoagulable abnormalities with coronary artery disease but a similar mechanism may operate to that in peripheral vessels.
This study demonstrates that hypercoagulable abnormalities, in particular the lupus anticoagulant, are common prior to arterial reconstruction for leg ischaemia and are independently predictive of subsequent failure. However, it is not clear what action should be taken if an abnormality is detected. Nitecki et al. advise avoidance of surgical revascularisation wherever possible. 4 If surgery is mandatory most investigators recommend careful anticoagulation 4' a8' 29 although there is no supporting data for this. Protein C deficiency has also been treated with plasma replacement 3° or anabolic steroids, 31 whilst prednisolone and aspirin therapy, in addition to anticoagulation, have been suggested for the treatment of the lupus anticoagulant. 9
